Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing (European Journal of Neurology, 2020)

(untitled) - Binks, S; Veldsman, M; Jacob, S; Maddison, P; Coebergh, J; Michael, S; Ramanathan, S; Leite, MI; Husain, M; Irani, SR